Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database

被引:27
|
作者
Hentosh, Samantha [1 ]
Zhu, Liang [2 ]
Patino, Jorge [1 ,3 ]
Furr, J. Weldon [4 ]
Rocha, Natalia P. [5 ]
Furr Stimming, Erin [1 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr UTHlth, McGovern Med Sch, Houston, TX USA
[2] Univ Texas Hlth Sci Ctr UTHlth, McGovern Med Sch, Dept Internal Med, Houston, TX USA
[3] HDSA Ctr Excellence UTHlth, Houston, TX USA
[4] Louisiana State Univ, Sci Ctr Shreveport, Sch Med, Shreveport, LA 71105 USA
[5] Univ Texas Hlth Sci Ctr, McGovern Med Sch, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX USA
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2021年 / 8卷 / 03期
关键词
Huntington's disease; sex-differences; enroll-HD;
D O I
10.1002/mdc3.13178
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Identifying sex-related differences is critical for enhancing our understanding of factors that may impact prognosis and advance treatments in Huntington's disease (HD). Objectives: To investigate if sex-related differences exist in clinical HD. Methods: Longitudinal study of the Enroll-HD database. Manifest HD patients were included in the analysis (N = 8401). Linear mixed models were used to assess motor, behavioral, and cognitive functioning over a series of four annual visits, and compared male and female HD gene carriers. Results: HD patients showed significant sex-dependent differences in motor, cognitive, and behavioral symptoms. Both sexes had worsened motor symptoms over the course of four visits, but there was a significant disparity between sexes, with females consistently presenting with more symptoms than males. For behavioral symptoms, specifically depressive symptoms, females had significantly more depressive symptoms, although self-reported symptoms in both sexes became less severe throughout time. Conclusions: Our analyses suggest that women have worse symptoms than men during the course of HD.
引用
收藏
页码:420 / 426
页数:7
相关论文
共 50 条
  • [41] Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD)
    Quinn, N
    Brown, R
    Craufurd, D
    Goldman, S
    Hodges, J
    Kieburtz, K
    Lindvall, O
    MacMillan, J
    Roos, R
    MOVEMENT DISORDERS, 1996, 11 (02) : 143 - 150
  • [42] Motor Abnormalities in Premanifest Persons with Huntington's Disease: The PREDICT-HD Study
    Biglan, Kevin M.
    Ross, Christopher A.
    Langbehn, Douglas R.
    Aylward, Elizabeth H.
    Stout, Julie C.
    Queller, Sarah
    Carlozzi, Noelle E.
    Duff, Kevin
    Beglinger, Leigh J.
    Paulsen, Jane S.
    MOVEMENT DISORDERS, 2009, 24 (12) : 1763 - 1772
  • [43] Psychiatric symptoms in Huntington's disease before diagnosis: The Predict-HD study
    Duff, Kevin
    Paulsen, Jane S.
    Beglinger, Leigh J.
    Langbehn, Douglas R.
    Stout, Julie C.
    BIOLOGICAL PSYCHIATRY, 2007, 62 (12) : 1341 - 1346
  • [44] Stem Cells for Huntington's Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease
    Badin, Romina Aron
    Bachoud-Levi, Anne-Catherine
    Bauer, Gerhard
    Busse-Morris, Monica
    Canals, Josep M.
    Capetian, Philipp
    Cattaneo, Elena
    Chen, Jefferson
    Cozzi, Emanuele
    Ellederova, Zdenka
    Goldman, Steven A.
    Gray, William
    Lai, Liangxue
    Li, Meng
    Morenkova, Anna
    Pan, Guangjin
    Pei, Zhong
    Martin, Unai Perpina
    Perrier, Anselme
    Reidling, John C.
    Rosseru, Anne E.
    Song, Jiwhan
    Thompson, Leslie M.
    Wheelock, Vicki
    JOURNAL OF HUNTINGTONS DISEASE, 2021, 10 (02) : 221 - 226
  • [45] NEW THERAPIES IN HUNTINGTON'S DISEASE (HD): CHALLENGES IN MODELLING FOR HEALTH ECONOMIC EVALUATIONS
    Kirvassilis, N.
    Patel, A.
    Thokala, P.
    VALUE IN HEALTH, 2022, 25 (01) : S58 - S58
  • [46] Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
    Kloeppel, Stefan
    Gregory, Sarah
    Scheller, Elisa
    Minkova, Lora
    Razi, Adeel
    Durr, Alexandra
    Roos, Raymund A. C.
    Leavitt, Blair R.
    Papoutsi, Marina
    Landwehrmeyer, G. Bernhard
    Reilmann, Ralf
    Borowsky, Beth
    Johnson, Hans
    Mills, James A.
    Owen, Gail
    Stout, Julie
    Scahill, Rachael I.
    Long, Jeffrey D.
    Rees, Geraint
    Tabrizi, Sarah J.
    EBIOMEDICINE, 2015, 2 (10): : 1420 - 1429
  • [47] Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry
    Anderson, David G.
    Haagensen, Mark
    Ferreira-Correia, Aline
    Pierson, Ronald
    Carr, Jonathan
    Krause, Amanda
    Margolis, Russell L.
    NEUROIMAGE-CLINICAL, 2019, 21
  • [48] Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutationA longitudinal follow–up study
    J. Lemiere
    M. Decruyenaere
    G. Evers-Kiebooms
    E. Vandenbussche
    R. Dom
    Journal of Neurology, 2004, 251 : 935 - 942
  • [49] Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains
    Ratovitski, Tamara
    Chaerkady, Raghothama
    Kammers, Kai
    Stewart, Jacqueline C.
    Zavala, Anialak
    Pletnikova, Olga
    Troncoso, Juan C.
    Rudnicki, Dobrila D.
    Margolis, Russell L.
    Cole, Robert N.
    Ross, Christopher A.
    JOURNAL OF PROTEOME RESEARCH, 2016, 15 (09) : 3266 - 3283
  • [50] Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - A longitudinal follow-up study
    Lemiere, J
    Decruyenaere, M
    Evers-Kiebooms, G
    Vandenbussche, E
    Dom, R
    JOURNAL OF NEUROLOGY, 2004, 251 (08) : 935 - 942